Currently treatments of type 2 diabetes mellitus (T2DM) include oral hypoglycemic agents, and injectable agents
Agents that agonize glucagon-like peptide 1 receptors, including those that co-agonize other anorexigenic hormone receptors, lead to substantial weight loss and benefits in people with varying obesity-related complications, with further trials underway
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a naturally occurring protective protein found in the stomachs gastric juices
Internal links: Medical Weight Loss, Peptides, Functional Medicine
Spinal melanotic schwannoma: A tumour with poor prognosis
This dual action improves metabolic health on several fronts blood sugar regulation, insulin sensitivity, and fat reduction and each of those improvements reduces the bodys inflammatory burden